Michael R Grunwald Selected Research

Michael R Grunwald Research Topics

Disease

17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2022 - 06/2013
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 01/2015
13	Neoplasms (Cancer) 12/2023 - 06/2013
8	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2023 - 01/2019
7	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 01/2015
6	Leukemia 10/2022 - 01/2016
5	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 02/2016
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 06/2013
3	Polycythemia Vera 12/2023 - 01/2020
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 05/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2019
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2004 - 01/2004
1	Essential Thrombocythemia 12/2023
1	Polycythemia (Erythrocytosis) 12/2023
1	Splenomegaly 12/2023
1	COVID-19 08/2023
1	Bronchiolitis Obliterans Syndrome 01/2023
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Cytopenia 01/2022
1	Hemorrhage 01/2022
1	Virus Diseases (Viral Diseases) 12/2021
1	Epstein-Barr Virus Infections 12/2021
1	Pathologic Complete Response 01/2020
1	Fatigue 01/2019
1	Hemorrhagic Cystitis 01/2019
1	Disseminated Intravascular Coagulation 03/2017
1	Multiple Myeloma 01/2015
1	GATA2 Deficiency 01/2015
1	Lymphoma (Lymphomas) 01/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2015
1	Takotsubo Cardiomyopathy 01/2012

Drug/Important Bio-Agent (IBA)

7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 03/2015
4	Busulfan (Busulfex)FDA Link 07/2023 - 03/2015
4	fludarabineIBA 07/2023 - 01/2020
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2013
4	fms-Like Tyrosine Kinase 3IBA 10/2019 - 06/2013
3	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 01/2020
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 06/2013
2	venetoclaxIBA 01/2022 - 01/2022
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2021 - 01/2020
2	ruxolitinibIBA 11/2021 - 02/2016
2	Calcineurin InhibitorsIBA 01/2021 - 01/2019
2	Syntex adjuvant formulationIBA 01/2019 - 01/2018
1	TESIBA 12/2023
1	HepcidinsIBA 12/2023
1	VaccinesIBA 08/2023
1	COVID-19 VaccinesIBA 08/2023
1	Hormones (Hormone)IBA 08/2023
1	fostamatinibIBA 01/2023
1	guadecitabineIBA 09/2022
1	atezolizumabIBA 09/2022
1	CPX-351IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	Factor Xa InhibitorsIBA 01/2022
1	thymoglobulin FDA Link 12/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	SteroidsIBA 11/2021
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	flt3 ligand protein (flt3 ligand)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Cytochrome P-450 CYP3AIBA 01/2019
1	2- (5- (3- chlorophenyl)- 6- (4- chlorophenyl)- 1- (1- (isopropylsulfonyl)- 3- methylbutan- 2- yl)- 3- methyl- 2- oxopiperidin- 3- yl)acetic acidIBA 01/2019
1	trametinibIBA 01/2019
1	AntigensIBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 03/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2015
1	Lenalidomide (CC 5013)FDA Link 01/2015
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	Imatinib Mesylate (Gleevec)FDA Link 06/2013
1	Fluorouracil (Carac)FDA LinkGeneric 01/2012
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2004
1	reteplase FDA Link 04/2004
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2004

Therapy/Procedure

25	Cell Transplantation 12/2023 - 03/2015
15	Transplantation 12/2023 - 05/2017
13	Therapeutics 12/2023 - 06/2013
5	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2018
3	Homologous Transplantation 11/2021 - 03/2015
2	Catheters 04/2004 - 01/2004
1	Splenectomy 12/2023
1	Drug Therapy (Chemotherapy) 11/2023
1	Stem Cell Transplantation 01/2023
1	Donor Selection 03/2022
1	MDC protocol 01/2022